Dainippon Sumitomo Pharma America (DSPA), a US subsidiary of Dainippon Sumitomo Pharma (DSP), has submitted a New Drug Application (NDA) to the FDA for Lurasidone, an investigational atypical
Scientists from Vienna have reportedly developed a new technique for producing vaccines for H1N1, ‘swine flu’, based on insect cells. The research was published in the Biotechnology Journal,
Intercell has started a phase II study in India as part of its clinical development program, for the investigational travelers’ diarrhea (TD) vaccine system. This placebo controlled field
India-based Zydus Cadila has received an approval from the Drug Controller General of India (DCGI) to conduct clinical trials for the H1N1 (swine flu) vaccine. The egg based,
Bio-Rad Laboratories and Axis-Shield have launched Bio-Rad’s BioPlex 2200 Anti-CCP test for the early detection of rheumatoid arthritis. The assay, which will run on Bio-Rad’s BioPlex 2200 system,
VBL Therapeutics has initiated Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201, orally-administered immune response modifier expected to
Insulet and Ypsomed have signed an agreement for the distribution of the OmniPod Insulin Management System in nine countries across Europe, China and Australia. As per the agreement,
LifeVantage has announced that the Protandim, a patented dietary supplement composed of five highly synergistic ‘indirect antioxidants’, is currently the subject of two human clinical trials at the
Anteis and Sanofi-aventis have entered into a supply and distribution partnership for Succeev, a Hyaluronic Acid (HA) based dermal filler. Available in Europe, Asia-Pacific, South America and the
Derma Sciences has finalized a three-year contract with a leading global healthcare products company to produce finger bandages. The agreement is expected to generate approximately $15 million in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.